For the study, researchers conducted a 12-week pilot clinical trial on 13 non-diabetic antiretroviral therapy treated people with HIV. The participants received metformin supplementation in addition to their antiretroviral therapy.
Researchers found that metformin increased the frequency of productively infected T cells expressing HIV proteins while preventing the virus from leaving the cells, noting this can help boost antiretrovirals.
As a result, metformin was shown to help reduce inflammation and improve immune system targeting of infected cells, according to the study.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
